← The Wire
STOKNasdaq
Stoke Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1623526
Restores protein expression with RNA medicine to treat genetic diseases
red 8-K · 90d
$1.86B
Market cap
$32.39
Last close
+1.2%
1D
+4.6%
5D
652K
Volume
Price · last 39 sessions-5.2%
May 4L $28.48 · H $34.18Jun 29
148
Total filings
Jun 4, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 4, 20268-KResults of OperationsMay 7, 202610-Q10-QMay 7, 2026DEFA14ADEFA14AApr 22, 2026DEF 14ADEF 14AApr 22, 20268-KExecutive Change · Reg FD DisclosureApr 7, 20268-KAuditor ChangeMar 27, 202610-K10-KMar 16, 20268-KExecutive ChangeMar 3, 20268-KMaterial Agreement · New Debt / ObligationJan 26, 20268-KResults of Operations · Reg FD DisclosureJan 12, 20268-KReg FD Disclosure · Company UpdateDec 5, 202510-Q10-QNov 4, 20258-KResults of OperationsNov 4, 20258-KExecutive ChangeOct 6, 20258-K/AShareholder VoteSep 18, 202510-Q10-QAug 12, 20258-KResults of Operations · Reg FD DisclosureAug 12, 20258-KReg FD DisclosureAug 11, 20258-KReg FD DisclosureJul 10, 20258-KShareholder VoteJun 4, 20258-KReg FD Disclosure · Company UpdateJun 4, 202510-Q10-QMay 13, 20258-KResults of OperationsMay 13, 2025DEFA14ADEFA14AApr 22, 2025DEF 14ADEF 14AApr 22, 202510-K10-KMar 18, 20258-KExecutive Change · Results of OperationsMar 18, 20258-KMaterial Agreement · Reg FD DisclosureFeb 18, 20258-KReg FD Disclosure · Company UpdateJan 7, 20258-KReg FD Disclosure · Company UpdateDec 6, 2024SC 13GSC 13GNov 14, 202410-Q10-QNov 5, 20248-KResults of OperationsNov 5, 20248-KCompany UpdateSep 10, 202410-Q10-QAug 7, 20248-KResults of OperationsAug 7, 2024SC 13GSC 13GJul 8, 20248-KExecutive ChangeJun 21, 20248-KShareholder VoteJun 6, 202410-Q10-QMay 6, 20248-KResults of OperationsMay 6, 20248-KExecutive ChangeApr 29, 2024DEFA14ADEFA14AApr 23, 2024DEF 14ADEF 14AApr 23, 20248-KMaterial Agreement · Reg FD DisclosureMar 28, 2024424B5424B5Mar 28, 2024424B5424B5Mar 26, 202410-K10-KMar 25, 20248-KReg FD DisclosureMar 25, 20248-KResults of OperationsMar 25, 2024SC 13GCOWEN FINANCIAL PRODUCTS LLCFeb 26, 20248-KReg FD Disclosure · Company UpdateJan 8, 20248-KMaterial Agreement · New Debt / ObligationDec 14, 20238-KReg FD DisclosureDec 1, 202310-Q10-QNov 7, 20238-KResults of OperationsNov 7, 2023SC 13GSTOKE THERAPEUTICS, INC.Nov 6, 20238-KShareholder VoteOct 26, 2023DEF 14ADEF 14ASep 28, 20238-KExecutive ChangeSep 20, 202310-Q10-QAug 7, 20238-KResults of OperationsAug 7, 20238-KReg FD DisclosureJul 25, 20238-KShareholder VoteJun 20, 2023DEFA14ADEFA14AMay 24, 202310-Q10-QMay 4, 20238-KResults of OperationsMay 4, 2023DEFA14ADEFA14AApr 27, 2023DEF 14ADEF 14AApr 27, 20238-KReg FD Disclosure · Company UpdateMar 15, 202310-K10-KMar 6, 20238-KResults of OperationsMar 6, 2023SC 13GMS INITIALFeb 10, 20238-KBylaw AmendmentFeb 3, 20238-KReg FD Disclosure · Company UpdateJan 9, 20238-KReg FD DisclosureDec 2, 202210-Q10-QNov 14, 20228-KResults of Operations · Reg FD DisclosureNov 14, 202210-Q10-QAug 8, 2022
Insider Activity
In the 90 days to Mar 20, 2026: 7 sold $3.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 20, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Sell | 8,692 | $33.64 | $292K |
| Mar 20, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Sell | 601 | $34.41 | $21K |
| Mar 19, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sell | 1,461 | $29.99 | $44K |
| Mar 18, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sell | 6,100 | $31.28 | $191K |
| Mar 18, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Sell | 4,222 | $31.28 | $132K |
| Mar 18, 2026 | Leggett ThomasChief Financial Officer | Sell | 2,173 | $31.28 | $68K |
| Mar 18, 2026 | Hoitt JasonChief Patient Officer | Sell | 1,762 | $31.28 | $55K |
| Mar 18, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sell | 483 | $31.79 | $15K |
| Mar 18, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Sell | 334 | $31.79 | $11K |
| Mar 18, 2026 | Leggett ThomasChief Financial Officer | Sell | 172 | $31.79 | $5K |
| Mar 18, 2026 | Hoitt JasonChief Patient Officer | Sell | 139 | $31.79 | $4K |
| Mar 18, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sell | 103 | $32.85 | $3K |
| Mar 18, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Sell | 72 | $32.85 | $2K |
| Mar 18, 2026 | Leggett ThomasChief Financial Officer | Sell | 37 | $32.85 | $1K |
| Mar 18, 2026 | Hoitt JasonChief Patient Officer | Sell | 30 | $32.85 | $986 |
| Mar 17, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sell | 3,577 | $32.74 | $117K |
| Mar 17, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sell | 2,587 | $33.38 | $86K |
| Mar 17, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Sell | 2,476 | $32.74 | $81K |
| Mar 17, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Sell | 1,791 | $33.38 | $60K |
| Mar 17, 2026 | Leggett ThomasChief Financial Officer | Sell | 1,274 | $32.74 | $42K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance